121. Mission-driven biotech investing, Josh Wolfe, Co-founder & Managing Partner, Lux Capital

In 2018, venture capital funds directed +$35B of investment to software, while directing $1.9B to synthetic biology. Why is this happening? Only 5% of people in Forbes 400 have formal scientific training, and it makes sense that people don't invest in things they don't understand. So this is a big problem.

1/ New Lux Capital letter to LPs — Q3 2023 theme: “ REALISM ” let’s get real…